
Sahar Javanmard
Examiner (ID: 6799, Phone: (571)270-3280 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1617, 1622, 1627 |
| Total Applications | 1199 |
| Issued Applications | 643 |
| Pending Applications | 130 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14273341
[patent_doc_number] => 20190133955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE
[patent_app_type] => utility
[patent_app_number] => 16/014093
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014093 | ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE | Jun 20, 2018 | Abandoned |
Array
(
[id] => 14338579
[patent_doc_number] => 20190151262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => USE OF N-ACETYLCYSTEINE AMIDE FOR DECREASING INTRACRANIAL PRESSURE
[patent_app_type] => utility
[patent_app_number] => 16/011225
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011225
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011225 | USE OF N-ACETYLCYSTEINE AMIDE FOR DECREASING INTRACRANIAL PRESSURE | Jun 17, 2018 | Abandoned |
Array
(
[id] => 15264423
[patent_doc_number] => 20190380945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Method for Degrading Bilirubin in Skin
[patent_app_type] => utility
[patent_app_number] => 16/010944
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010944 | Method for degrading bilirubin in skin | Jun 17, 2018 | Issued |
Array
(
[id] => 13618519
[patent_doc_number] => 20180360811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections
[patent_app_type] => utility
[patent_app_number] => 16/009751
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009751
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/009751 | Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections | Jun 14, 2018 | Abandoned |
Array
(
[id] => 16572118
[patent_doc_number] => 10894029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Neuroprotective compositions and their use
[patent_app_type] => utility
[patent_app_number] => 16/009490
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 4799
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/009490 | Neuroprotective compositions and their use | Jun 14, 2018 | Issued |
Array
(
[id] => 13444033
[patent_doc_number] => 20180273559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => GOLD COMPLEXES OF ALKYLATED PHOSPHINES
[patent_app_type] => utility
[patent_app_number] => 15/993163
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15993163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/993163 | Gold complexes of alkylated phosphines | May 29, 2018 | Issued |
Array
(
[id] => 17451776
[patent_doc_number] => 11266611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => More potent and less toxic formulations of epinephrine and methods of medical use
[patent_app_type] => utility
[patent_app_number] => 15/991501
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8216
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/991501 | More potent and less toxic formulations of epinephrine and methods of medical use | May 28, 2018 | Issued |
Array
(
[id] => 13444031
[patent_doc_number] => 20180273558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => COMPOSITION CONTAINING A GOLD (I) COMPLEX AND CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 15/990289
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990289
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990289 | Composition containing a gold (I) complex and cancer cells | May 24, 2018 | Issued |
Array
(
[id] => 13425253
[patent_doc_number] => 20180264169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC
[patent_app_type] => utility
[patent_app_number] => 15/986371
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986371 | COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC | May 21, 2018 | Abandoned |
Array
(
[id] => 13220503
[patent_doc_number] => 10124011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Methods of treating erectile dysfunction
[patent_app_type] => utility
[patent_app_number] => 15/982713
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6812
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982713
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982713 | Methods of treating erectile dysfunction | May 16, 2018 | Issued |
Array
(
[id] => 13424853
[patent_doc_number] => 20180263969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 15/982974
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982974 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS | May 16, 2018 | Abandoned |
Array
(
[id] => 14818315
[patent_doc_number] => 10406143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Methods for treatment of fabry disease
[patent_app_type] => utility
[patent_app_number] => 15/974222
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12640
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/974222 | Methods for treatment of fabry disease | May 7, 2018 | Issued |
Array
(
[id] => 13548667
[patent_doc_number] => 20180325881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => Methods for Treatment of Fabry Disease
[patent_app_type] => utility
[patent_app_number] => 15/974217
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974217
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/974217 | Methods for treatment of Fabry disease | May 7, 2018 | Issued |
Array
(
[id] => 13602599
[patent_doc_number] => 20180352848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => SMOKABLE CANNABIS-BASED PRODUCT WITH REDUCED PSYCHOACTIVE EFFECTS
[patent_app_type] => utility
[patent_app_number] => 15/968053
[patent_app_country] => US
[patent_app_date] => 2018-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15968053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/968053 | SMOKABLE CANNABIS-BASED PRODUCT WITH REDUCED PSYCHOACTIVE EFFECTS | Apr 30, 2018 | Abandoned |
Array
(
[id] => 16215027
[patent_doc_number] => 10730825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
[patent_app_type] => utility
[patent_app_number] => 15/967080
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 31
[patent_no_of_words] => 37326
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/967080 | Methods for the treatment of diabetic retinopathy and other ophthalmic diseases | Apr 29, 2018 | Issued |
Array
(
[id] => 16518620
[patent_doc_number] => 10869822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Compositions for treatment of dermatological diseases and conditions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/962436
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 11916
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962436
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962436 | Compositions for treatment of dermatological diseases and conditions and methods of use thereof | Apr 24, 2018 | Issued |
Array
(
[id] => 17525648
[patent_doc_number] => 11298314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same
[patent_app_type] => utility
[patent_app_number] => 16/311960
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 77
[patent_no_of_words] => 38320
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311960
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311960 | Injectable composition for localized fat reduction without pain, edema, and side effects, and method for preparing same | Apr 19, 2018 | Issued |
Array
(
[id] => 13457597
[patent_doc_number] => 20180280341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/957724
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957724
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/957724 | MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS | Apr 18, 2018 | Abandoned |
Array
(
[id] => 13586271
[patent_doc_number] => 20180344684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF SLEEP DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/954536
[patent_app_country] => US
[patent_app_date] => 2018-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/954536 | CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF SLEEP DISORDERS | Apr 15, 2018 | Abandoned |
Array
(
[id] => 13942287
[patent_doc_number] => 10206888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Cannabis-based therapeutic product for treatment of chronic pain
[patent_app_type] => utility
[patent_app_number] => 15/952875
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10637
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952875
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/952875 | Cannabis-based therapeutic product for treatment of chronic pain | Apr 12, 2018 | Issued |